Published in Eur J Immunol on December 01, 1982
Accessory cell function of liver granuloma macrophages of Schistosoma mansoni-infected mice. Infect Immun (1983) 0.83
Nitric oxide production and nitric oxide synthase type 2 expression by cotton rat (Sigmodon hispidus) macrophages reflect the same pattern as human macrophages. Dev Comp Immunol (2009) 0.78
Anti-I-J alloantisera elicited by immunization of B10.A(3R) (I-Jb) mice with bone marrow-derived macrophages from B10.A(5R) (I-Jk) mice. Immunology (1986) 0.75
Dissection of macrophage tumoricidal and protozoacidal activities using T-cell hybridomas and recombinant lymphokines. Infect Immun (1985) 0.75
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature (1992) 4.42
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev (2001) 3.65
Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci (2000) 2.46
Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science (1990) 2.32
Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol (1997) 2.28
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res (2001) 2.13
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol (1993) 2.09
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics (1991) 2.03
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology (2009) 2.00
Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery (1982) 1.99
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91
Plexiform neurofibromas in NF1: toward biologic-based therapy. Neurology (2002) 1.90
High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas. Oncogene (2008) 1.84
Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet (2000) 1.76
Reoperative surgery for periampullary adenocarcinoma. Arch Surg (1991) 1.73
Inhibition of immune responses in vitro by specific antiserums to Ia antigens. Science (1975) 1.65
Effects of anti-Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A-reactive cells to the I-J subregion of the H-2 gene complex. J Exp Med (1976) 1.60
The role of I region gene products in macrophage - T lymphocyte interaction. Immunol Rev (1978) 1.58
Interdomain binding mediates tumor growth suppression by the NF2 gene product. Oncogene (1997) 1.55
Cancer-related gene expression profiles in NF1-associated pilocytic astrocytomas. Neurology (2001) 1.54
Mechanisms generating functionally heterogeneous macrophages: chaos revisited. J Leukoc Biol (1993) 1.50
Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet (1988) 1.47
A first-generation porcine whole-genome radiation hybrid map. Mamm Genome (1999) 1.45
Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet (1993) 1.45
Differential effects of cAMP in neurons and astrocytes. Role of B-raf. J Biol Chem (1999) 1.43
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol (1993) 1.43
Dark-light: model for nightblindness from the human rhodopsin Gly-90-->Asp mutation. Proc Natl Acad Sci U S A (1995) 1.41
What is a surgical oncologist? Ann Surg Oncol (1994) 1.40
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
National patterns of care for pancreatic cancer. Results of a survey by the Commission on Cancer. Ann Surg (1996) 1.35
Phenotypic expression of juvenile X-linked retinoschisis in Swedish families with different mutations in the XLRS1 gene. Arch Ophthalmol (2000) 1.34
Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet (1999) 1.29
Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1. Hum Mol Genet (2000) 1.27
Nomenclature for factors of the SLA system, update 2008. Tissue Antigens (2009) 1.26
Surgical considerations in the management of hepatic neoplasia. Semin Oncol (1983) 1.24
Role of I-region gene products in macrophage induction of an antibody response. II. Restriction at the level of T cell in recognition of I-J-subregion macrophage determinants. J Exp Med (1980) 1.24
Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol (2007) 1.22
Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases. J Neuropathol Exp Neurol (2001) 1.21
Merlin differentially associates with the microtubule and actin cytoskeleton. J Neurosci Res (1998) 1.21
Juvenile X-linked retinoschisis from XLRS1 Arg213Trp mutation with preservation of the electroretinogram scotopic b-wave. Am J Ophthalmol (1999) 1.18
Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17
NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol (2001) 1.16
Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol (2000) 1.16
Differential immunocompetence of macrophages derived using macrophage or granulocyte-macrophage colony-stimulating factor. J Leukoc Biol (1992) 1.16
Genetic induction of tumorigenesis in swine. Oncogene (2006) 1.14
Bilateral macular atrophy in blue cone monochromacy (BCM) with loss of the locus control region (LCR) and part of the red pigment gene. Mol Vis (1999) 1.14
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol (2000) 1.14
Nutritional studies with Pseudomonas aeruginosa grown on inorganic sulfur sources. J Bacteriol (1978) 1.13
Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med (1984) 1.12
Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation. Proc Natl Acad Sci U S A (1992) 1.11
Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer (1984) 1.10
Antigen-specific T cell activation results in an increase in cytoplasmic free calcium. J Immunol (1985) 1.09
Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma. Neurology (2006) 1.09
Expression of Ia antigens on T and B cells and their relationship to immune-response functions. Transplant Rev (1976) 1.09
Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet (2000) 1.09
An improved method for preparing anti-B lymphocyte serum. Nat New Biol (1971) 1.09
Linkage relationship of X-linked juvenile retinoschisis with Xp22.1-p22.3 probes. Am J Hum Genet (1990) 1.08
The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08
Malignant clear cell acrospiroma. Cancer (1978) 1.07
The expression of Ia antigenic determinants on macrophages required for the in vitro antibody response. J Immunol (1979) 1.07
Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene (2011) 1.05
Molecular responses of macrophages to porcine reproductive and respiratory syndrome virus infection. Virology (1999) 1.05
Macrophage heterogeneity occurs through a developmental mechanism. Proc Natl Acad Sci U S A (1991) 1.04
Porcine colonization of the Americas: a 60k SNP story. Heredity (Edinb) (2012) 1.04
Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis (1995) 1.02
A Colombian family with X-linked juvenile retinoschisis with three affected females finding of a frameshift mutation. Ophthalmic Genet (1999) 1.01
A genomic scan of porcine reproductive traits reveals possible quantitative trait loci (QTLs) for number of corpora lutea. Mamm Genome (1999) 1.00
Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia (2001) 0.99
An RNA helicase, RHIV -1, induced by porcine reproductive and respiratory syndrome virus (PRRSV) is mapped on porcine chromosome 10q13. Microb Pathog (2000) 0.99
Interval mapping of growth in divergent swine cross. Mamm Genome (1999) 0.99
Regulation of IL-1 and TNF-alpha expression during the differentiation of bone marrow derived macrophage. J Immunol (1989) 0.99
Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet (1993) 0.99
Tumorigenesis in neurofibromatosis: new insights and potential therapies. Trends Mol Med (2001) 0.97
The EWSR1/NR4A3 fusion protein of extraskeletal myxoid chondrosarcoma activates the PPARG nuclear receptor gene. J Pathol (2009) 0.97
Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma. Neuroscience (2010) 0.96
Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells. Cell Immunol (1972) 0.96
Carcinogenesis of the skin. 3. The contribution of elemental sulfur and of organic sulfur compounds. Cancer Res (1965) 0.96
Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood (1989) 0.96
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene (2012) 0.95
Dependence on antibody for induction of chemiluminescence in polymorphonuclear leukocytes by herpes simplex virus. Invest Ophthalmol Vis Sci (1985) 0.95
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials. J Clin Oncol (1991) 0.95
The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology (2006) 0.95
Transcription of the blk gene in human B lymphocytes is controlled by two promoters. J Biol Chem (1995) 0.94
Ezrin, radixin, and moesin are components of Schwann cell microvilli. J Neurosci Res (2001) 0.94
Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res (1997) 0.94
A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA (1984) 0.94
Breast feeding and maternal-donor renal allografts. Possibly the original donor-specific transfusion. Transplantation (1984) 0.94
Spectrum of color gene deletions and phenotype in patients with blue cone monochromacy. Hum Genet (2000) 0.94
Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells. J Neurosci Res (1996) 0.94
Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells. Oncogene (2006) 0.93
Novel mutations in XLRS1 causing retinoschisis, including first evidence of putative leader sequence change. Hum Mutat (1999) 0.93
Clonal analysis of gene expression by PCR. Biotechniques (1990) 0.93
Evaluating evolutionary divergence with microsatellites. J Mol Evol (1998) 0.93
Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett (1996) 0.93
Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas. Vet Pathol (2009) 0.92
The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ (1995) 0.92
Rearrangement of immunoglobulin and T-cell receptor genes in Hodgkin's disease. Am J Pathol (1988) 0.91
1st pig gene mapping workshop (PGM1), 7 August 1992, Interlaken, Switzerland. Anim Genet (1993) 0.90